A new treatment which could give vulnerable patients extra protection against the flu virus is being offered in Nottingham as part of an international study testing its effectiveness. Flu is a serious problem not only for those with existing medical conditions but also for medical centres which come under pressure when dealing with numerous cases.

The sudden appearance of this symptom could be your body's alarm bell going off, says a top infectious disease doctor.

As cold and flu season ramps up, it can be difficult to tell the differences between these common illnesses. Dr. Bernice Jimenez, a resident physician in the UAMS Internal

A hormone known for regulating energy balance also helps the body cope with influenza by triggering protective responses in the brain, a study led by UT Southwestern Medical Center researchers shows.

Researchers have developed a new type of flu treatment that could have a dramatic impact on the fight against influenza and potentially, other viruses too. This method involves an antibody cocktail, and when it was tested in a mouse model of weakened ...

The deal, one of two multibillion-dollar buyouts from Merck this year, centers around a drug that could become an alternative to vaccines for flu prevention.

Merck, the New Jersey-based pharmaceutical giant, will pay Cidara stockholders $221.50 a share in the all-cash deal. Cidara is currently developing a drug designed to prevent the flu and has at least three other therapies for solid tumors in its pipeline.